EGFR and lung carcinoma: Since the EGFR mutation is a clinical significant molecular characteristic of lung cancer, the effect of Quinalizarin on the radiosensitivity of the EGFR mutant adenocarcinoma cells H1975 and HCC87 was also explored in the current study.